Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.34 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.34 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PYGB | P11216 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18026508 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL19294039 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL8281882 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL27108746 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL20226178 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL19293900 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL20307020 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL19293898 | 1.00 | L3MBTL1 (0.37) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL21907408 | 0.88 | L3MBTL1 (0.36) | L3MBTL1MAPTLGALS1LGALS3LGALS9 | |
| SCHEMBL18251216 | 0.84 | L3MBTL1 (0.47) | L3MBTL1MAPTLGALS1LGALS3LGALS9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8445611-B2 | Antimicrobial polymers | UNIVERSITY OF MASSACHUSETTS (US) | 2013-05-21 | — | — | US | disclosed |
| US-20120195849-A1 | ANTIMICROBIAL POLYMERS | MIDCAP FINANCIAL SBIC, LP, AS ADMINISTRATIVE AGENT | 2012-08-02 | — | — | US | disclosed |
| US-8153739-B2 | Antimicrobial polymers | UNIVERSITY OF MASSACHUSETTS (US) | 2012-04-10 | — | — | US | disclosed |
| US-20100317870-A1 | ANTIMICROBIAL POLYMERS | MIDCAP FINANCIAL SBIC, LP, AS ADMINISTRATIVE AGENT | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317870-A1 | ANTIMICROBIAL POLYMERS | CGAS, NOD2, NLRP1 | L3MBTL1 2218/4885MAPT 877/4885LGALS1 1712/4885 |
| US-20120195849-A1 | ANTIMICROBIAL POLYMERS | CGAS, NOD2, NLRP1 | L3MBTL1 2218/4885MAPT 877/4885LGALS1 1712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.